SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Unity Biotechnology Q1 EPS $(0.590) Misses $(0.510) Estimate

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.590) per share which missed the analyst consensus estimate of $(0.510) by 15.69 percent. This is a 34.09 percent decrease over losses of $(0.440) per

Benzinga · 05/07/2020 20:45

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.590) per share which missed the analyst consensus estimate of $(0.510) by 15.69 percent. This is a 34.09 percent decrease over losses of $(0.440) per share from the same period last year.